Gender differences in lung cancer: Have we really come a long way, baby?

作者: Jemi Olak , Yolanda Colson

DOI: 10.1016/J.JTCVS.2004.05.025

关键词:

摘要: 346 The Journal of Thoracic and Cardio I t has been estimated that 173,770 new lung cancers will be diagnosed in the USA 2004, 80,600 (46.3%) women. It also 68,510 women die cancer which represents a 4.2% increase from 2001, when took lives 65,606 Lung currently accounts for 12.7% all United States 28.5% deaths. In 1987, surpassed breast to become leading cause death among fact, now kills more annually than breast, uterine, ovarian combined. Unfortunately, have come long way, but not along good path. Between 1950 1994, female mortality increased 500%, 3% 22%. 1965, approximately 30,000 US died 10 categories tobacco-related illnesses, by 1985 figure had risen 106,000. That diseases including are an increasingly major health problem is undeniable.

参考文章(64)
D Hoffmann, S S Hecht, The relevance of tobacco-specific nitrosamines to human cancer. Cancer surveys. ,vol. 8, pp. 273- 294 ,(1989)
Aage Haugen, David Ryberg, Allan Hewer, David H. Phillips, Steen Mollerup, Sex Differences in Lung CYP1A1 Expression and DNA Adduct Levels among Lung Cancer Patients Cancer Research. ,vol. 59, pp. 3317- 3320 ,(1999)
Kei Nakachi, Kazue Imai, Kaname Kawajiri, Shin Ichi Hayashi, Polymorphisms of the CYP1A1 and Glutathione S-Transferase Genes Associated with Susceptibility to Lung Cancer in Relation to Cigarette Dose in a Japanese Population Cancer Research. ,vol. 53, pp. 2994- 2999 ,(1993)
E Whitley, W Ahrens, V Gaborieau, J Heinrich, K H Jöckel, L Kreienbrock, S Mallone, F Merletti, F Roesch, P Zambon, L Simonato, M Kreuzer, P Boffetta, Gender differences in lung cancer risk by smoking: a multicentre case-control study in Germany and Italy. British Journal of Cancer. ,vol. 82, pp. 227- 233 ,(2000) , 10.1054/BJOC.1999.0904
Aage Haugen, Alan Hewer, David Ryberg, David H. Phillips, Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients. Cancer Research. ,vol. 54, pp. 5801- 5803 ,(1994)
Ernst L. Wynder, Dietrich Hoffmann, Smoking and Lung Cancer: Scientific Challenges and Opportunities Cancer Research. ,vol. 54, pp. 5284- 5295 ,(1994)
JILL M. SIEGFRIED, MARY ANN A. DeMICHELE, JAY D. HUNT, AUTUMN GAITHER DAVIS, KUNWAR P. VOHRA, JOSEPH M. PILEWSKI, Expression of mRNA for gastrin-releasing peptide receptor by human bronchial epithelial cells. Association with prolonged tobacco exposure and responsiveness to bombesin-like peptides. American Journal of Respiratory and Critical Care Medicine. ,vol. 156, pp. 358- 366 ,(1997) , 10.1164/AJRCCM.156.2.9608047
K S Albain, V W Rusch, J J Crowley, T W Rice, A T Turrisi, J K Weick, V A Lonchyna, C A Presant, R J McKenna, D R Gandara, Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. Journal of Clinical Oncology. ,vol. 13, pp. 1880- 1892 ,(1995) , 10.1200/JCO.1995.13.8.1880
M Paesmans, J P Sculier, P Libert, G Bureau, G Dabouis, J Thiriaux, J Michel, O Van Cutsem, R Sergysels, P Mommen, Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party. Journal of Clinical Oncology. ,vol. 13, pp. 1221- 1230 ,(1995) , 10.1200/JCO.1995.13.5.1221
M K Ferguson, C Skosey, P C Hoffman, H M Golomb, Sex-associated differences in presentation and survival in patients with lung cancer. Journal of Clinical Oncology. ,vol. 8, pp. 1402- 1407 ,(1990) , 10.1200/JCO.1990.8.8.1402